logo
Plus   Neg
Share
Email

Regeneron, Zoetis Announce Research Collaboration - Quick Facts

Regeneron Pharmaceuticals, Inc. (REGN) and Zoetis Inc. (ZTS) announced a five-year collaboration to research the use of Regeneron's monoclonal antibody therapeutics in animals and discover new veterinary treatments. Regeneron has granted Zoetis a license for its VelocImmune antibody technology, which Zoetis will use to develop monoclonal antibodies modified for species-specific use in companion and livestock animals.

Regeneron will receive a license fee, approval and sales milestone payments and royalties on any potential veterinary treatments.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Electronics retailer Best Buy Co. Inc. (BBY), Wednesday said it has agreed to buy GreatCall Inc. for $800 million in cash. GreatCall is a provider of connected health and personal emergency response services to the aging population, with more than 900,000 paying subscribers. It offers easy-to-use... Rio Tinto PLC (RIO) is reportedly seeking to divest its Canadian iron-ore business for a possible consideration worth $6 billion. According to Sky News, the Anglo-Australian mining giant has begun courting potential bidders for its $6 billion Canadian iron-ore? operations as it seeks to take advantage... Brewer Constellation Brands Inc. will invest C$5 billion, or $4 billion, in Canadian cannabis company Canopy Growth Corp. as part of an expansion of the two companies' strategic partnership, the companies said Wednesday. Canopy Growth is Canada's largest medical marijuana producer. Shares of Canopy Growth are gaining more than 27 percent in the regular trading.
Follow RTT